Vertex/CRISPR Are First To US FDA With A CRISPR Gene-Editing Therapy For Sickle Cell Disease

 
• By Jessica Merrill
milestone
The filing of exa-cel marks a milestone for CRISPR • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies